carvedilol has been researched along with Pulmonary Arterial Hypertension in 2 studies
Pulmonary Arterial Hypertension: A progressive rare pulmonary disease characterized by high blood pressure in the PULMONARY ARTERY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Late carvedilol treatment did not lead to recovery of RV function." | 1.62 | [ ( Ahmadi, A; Beanlands, R; deKemp, RA; Mielniczuk, LM; Schock, S; Staines, WA; Stewart, DJ; Zelt, JGE, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zelt, JGE | 1 |
| Schock, S | 1 |
| deKemp, RA | 1 |
| Stewart, DJ | 1 |
| Staines, WA | 1 |
| Ahmadi, A | 1 |
| Beanlands, R | 1 |
| Mielniczuk, LM | 1 |
| Thenappan, T | 1 |
| Weir, EK | 1 |
| Prins, KW | 1 |
| Pritzker, MR | 1 |
| Archer, SL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Beta Blockers in Pulmonary Arterial Hypertension (PAH) A Pilot Study of Efficacy and Safety[NCT02120339] | Phase 1 | 5 participants (Actual) | Interventional | 2014-05-31 | Terminated (stopped due to Low enrollment) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for carvedilol and Pulmonary Arterial Hypertension
| Article | Year |
|---|---|
[
Topics: Animals; Carvedilol; Disease Models, Animal; Echocardiography; Ephedrine; Male; Positron-Emission To | 2021 |
Carvedilol for Treatment of Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.
Topics: Antihypertensive Agents; Carvedilol; Feasibility Studies; Female; Follow-Up Studies; Humans; Male; M | 2021 |